Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
49.9M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
34.1M
-
Shares change
-
+8.76M
-
Total reported value, excl. options
-
$459M
-
Value change
-
+$118M
-
Number of buys
-
48
-
Number of sells
-
-9
-
Price
-
$13.45
Significant Holders of HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) as of Q3 2023
68 filings reported holding HLVX - HilleVax, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.1M shares
of 49.9M outstanding shares and own 68.46% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (9.78M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4M shares), Deep Track Capital, LP (2.9M shares), VR Adviser, LLC (2.04M shares), Carlyle Group Inc. (1.84M shares), FRANKLIN RESOURCES INC (1.77M shares), BRAIDWELL LP (1.45M shares), T. Rowe Price Investment Management, Inc. (1.43M shares), BlackRock Inc. (1.29M shares), and VANGUARD GROUP INC (1.15M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.